The Extended Utilization of Bulking Agents in Pediatric Urology

Area of Science:

• Pediatric Urology
• Minimally Invasive Surgery
• Urologic Therapeutics

Background:

• Traditional treatments for pediatric urinary incontinence and vesicoureteral reflux (VUR) involve complex surgeries and prolonged hospital stays.
• Endoscopic injection (EI) using bulking agents has emerged as an alternative since its introduction in 1973.
• Recent advancements have increased interest in EI for diverse pediatric urologic conditions.

Purpose of the Study:

• To review the latest literature on the application of bulking agents in pediatric urology.
• To summarize current evidence regarding endoscopic injection techniques and outcomes.
• To highlight the role of bulking agents in managing pediatric urologic disorders.

Main Methods:

• Literature review of recent studies on endoscopic bulking agents in pediatric urology.
• Analysis of applications for urinary incontinence and vesicoureteral reflux (VUR).
• Evaluation of advancements in injection techniques and bulking agent properties.

Main Results:

• Recent literature emphasizes EI of bulking agents at the bladder neck for urinary incontinence.
• EI is also utilized for VUR in patients with anatomical abnormalities and for incontinence catheterizable channels.
• Development of advanced EI techniques and stable bulking agents facilitates treatment for various urologic conditions.

Conclusions:

• Endoscopic injection of bulking agents is a valuable minimally invasive option for pediatric urologic conditions.
• This technique provides an effective alternative to traditional reconstructive surgery.
• It expands the treatment options available to pediatric urologists for incontinence and VUR.